Recently, For Future Equity Investment Management (Guangzhou) Co., Ltd. (For Future Capital) launched a healthcare fund in Changzhou West Taihu Lake International Medical Industrial Park (WIM).

As the second phase of For Future Capital’s healthcare fund, it is co-invested by Guangdong By-Health Biotechnology, Chengcheng Investment, Changzhou West Taihu Emerging Industry Investment Fund, and high-net-worth individuals (HNWI). The fund initially raised 150 million yuan.

Founded in 2018, For Future Capital currently has nearly 8 billion yuan in regulatory assets under management. The first phase of its healthcare fund mainly invests in commercial health insurance, new retail pharmacies, medical equipment, etc. The second phase will focus on innovation technologies such as medical equipment, diagnostic technology, improved new rugs, and precision medicine.

At present, Changzhou WIM has gathered more than 500 medical device-related enterprises in orthopedics, dentistry, in vitro diagnostic equipment and consumables, sanitary materials and materials, surgical equipment and surgical consumables, and rehabilitation aids and consumables.